Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.

Lancet 2026 Jan 10

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.

Related Questions

Under what circumstances would you consider treating uncomplicated gonorrhea with zoliflodacin instead of the standard treatment regimen with ceftriaxone and azithromycin?